Antimicrobial Resistance in Staphylococcus aureus in Australian Teaching Hospitals, 1989-1999
An annual survey of antimicrobial resistance in clinical isolates of Staphylococcus aureus was conducted in 21 Australian teaching hospital microbiology laboratories in eight major cities from 1989 to 1999. A total of 19,000 isolates were tested for susceptibility to 18 antimicrobials, with 3795 bei...
Gespeichert in:
| Veröffentlicht in: | Microbial drug resistance (Larchmont, N.Y.) N.Y.), 2003-06, Vol.9 (2), p.155-160 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 160 |
|---|---|
| container_issue | 2 |
| container_start_page | 155 |
| container_title | Microbial drug resistance (Larchmont, N.Y.) |
| container_volume | 9 |
| creator | Nimmo, Graeme R. Bell, Jan M. Mitchell, David Gosbell, Iain B. Pearman, John W. Turnidge, John D. |
| description | An annual survey of antimicrobial resistance in clinical isolates of
Staphylococcus aureus
was conducted in 21 Australian teaching hospital microbiology laboratories in eight major cities from 1989
to 1999. A total of 19,000 isolates were tested for susceptibility to 18 antimicrobials, with 3795 being methicillin-resistant (MRSA). Resistance to ciprofloxacin in MRSA increased from 4.9% to 75.9%. The
proportion of MRSA resistant to erythromycin decreased significantly (99.0%-88.9%), as did that to trimethoprim (98.4%-82.4%) and to tetracycline (96.5%-80.1%). The proportion of MRSA isolated increased
in Sydney, Melbourne, Canberra, Adelaide, Perth, and Darwin, but not in Brisbane. The proportion in Hobart peaked in 1994. MRSA in Perth were predominantly non-multiresistant (nmMRSA) throughout the survey
(
i.e
., resistant to less than three of eight indicator antibiotics) due mainly to local strains that originated in the community. The proportion of nmMRSA increased to modest levels in the other
cities. In eastern cities, this was due to the appearance of strains closely related to nmMRSA seen in other countries of the southwestern Pacific. |
| doi_str_mv | 10.1089/107662903765826741 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73434789</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73434789</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-53d3c55efc460525ad72af2b9a788ed1a2787a83fe79d5f64ec546c2feda32aa3</originalsourceid><addsrcrecordid>eNqNkU1LHEEQhhuJxFXzBzyEIYecHO3vj-OyGBUEwY9jGGp7amIvsz2b7pnD_ntbdiFgDnp6i6qnXqh6CTlj9IJR6y4ZNVpzR4XRynJtJDsgM-YEq62U9kupC1AXQh6R45xXlFLFtPhKjhi3nFpKZ-T3PI5hHXwalgH66gFzyCNEj1WI1eMIm5dtP_jB-ylXMCUsUgbzKY8J-gCxekLwLyH-qW6GvAkj9Pm8Ys66mjnnTslhVzr4ba8n5PnX1dPipr67v75dzO9qL6keayVa4ZXCzktNFVfQGg4dXzow1mLLgBtrwIoOjWtVpyV6JbXnHbYgOIA4IT93vps0_J0wj806ZI99DxGHKTdGSCGNdR-CzBrnjOMF_PEOXA1TiuWIhlPpuNWGFYjvoPK-nBN2zSaFNaRtw2jzFlHzf0Rl6fveeVqusf23ss-kAHYHvLUhxj7gEtP4Ge9Xol-cAQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204928671</pqid></control><display><type>article</type><title>Antimicrobial Resistance in Staphylococcus aureus in Australian Teaching Hospitals, 1989-1999</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>Nimmo, Graeme R. ; Bell, Jan M. ; Mitchell, David ; Gosbell, Iain B. ; Pearman, John W. ; Turnidge, John D.</creator><creatorcontrib>Nimmo, Graeme R. ; Bell, Jan M. ; Mitchell, David ; Gosbell, Iain B. ; Pearman, John W. ; Turnidge, John D. ; AGAR</creatorcontrib><description>An annual survey of antimicrobial resistance in clinical isolates of
Staphylococcus aureus
was conducted in 21 Australian teaching hospital microbiology laboratories in eight major cities from 1989
to 1999. A total of 19,000 isolates were tested for susceptibility to 18 antimicrobials, with 3795 being methicillin-resistant (MRSA). Resistance to ciprofloxacin in MRSA increased from 4.9% to 75.9%. The
proportion of MRSA resistant to erythromycin decreased significantly (99.0%-88.9%), as did that to trimethoprim (98.4%-82.4%) and to tetracycline (96.5%-80.1%). The proportion of MRSA isolated increased
in Sydney, Melbourne, Canberra, Adelaide, Perth, and Darwin, but not in Brisbane. The proportion in Hobart peaked in 1994. MRSA in Perth were predominantly non-multiresistant (nmMRSA) throughout the survey
(
i.e
., resistant to less than three of eight indicator antibiotics) due mainly to local strains that originated in the community. The proportion of nmMRSA increased to modest levels in the other
cities. In eastern cities, this was due to the appearance of strains closely related to nmMRSA seen in other countries of the southwestern Pacific.</description><identifier>ISSN: 1076-6294</identifier><identifier>EISSN: 1931-8448</identifier><identifier>DOI: 10.1089/107662903765826741</identifier><identifier>PMID: 12820800</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Anti-Infective Agents - pharmacology ; Antibiotics ; Antimicrobial agents ; Australia - epidemiology ; Cities ; Cross Infection - microbiology ; Drug Resistance, Bacterial ; Epidemiology ; Hospitals, Teaching ; Humans ; Methicillin Resistance ; Microbial Sensitivity Tests ; Microbiology ; Polls & surveys ; Public health ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - microbiology ; Staphylococcus aureus - drug effects ; Time Factors</subject><ispartof>Microbial drug resistance (Larchmont, N.Y.), 2003-06, Vol.9 (2), p.155-160</ispartof><rights>Copyright Mary Ann Liebert Inc. Jun 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-53d3c55efc460525ad72af2b9a788ed1a2787a83fe79d5f64ec546c2feda32aa3</citedby><cites>FETCH-LOGICAL-c406t-53d3c55efc460525ad72af2b9a788ed1a2787a83fe79d5f64ec546c2feda32aa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.liebertpub.com/doi/epdf/10.1089/107662903765826741$$EPDF$$P50$$Gmaryannliebert$$H</linktopdf><linktohtml>$$Uhttps://www.liebertpub.com/doi/full/10.1089/107662903765826741$$EHTML$$P50$$Gmaryannliebert$$H</linktohtml><link.rule.ids>314,780,784,3042,21723,27924,27925,55291,55303</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12820800$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nimmo, Graeme R.</creatorcontrib><creatorcontrib>Bell, Jan M.</creatorcontrib><creatorcontrib>Mitchell, David</creatorcontrib><creatorcontrib>Gosbell, Iain B.</creatorcontrib><creatorcontrib>Pearman, John W.</creatorcontrib><creatorcontrib>Turnidge, John D.</creatorcontrib><creatorcontrib>AGAR</creatorcontrib><title>Antimicrobial Resistance in Staphylococcus aureus in Australian Teaching Hospitals, 1989-1999</title><title>Microbial drug resistance (Larchmont, N.Y.)</title><addtitle>Microb Drug Resist</addtitle><description>An annual survey of antimicrobial resistance in clinical isolates of
Staphylococcus aureus
was conducted in 21 Australian teaching hospital microbiology laboratories in eight major cities from 1989
to 1999. A total of 19,000 isolates were tested for susceptibility to 18 antimicrobials, with 3795 being methicillin-resistant (MRSA). Resistance to ciprofloxacin in MRSA increased from 4.9% to 75.9%. The
proportion of MRSA resistant to erythromycin decreased significantly (99.0%-88.9%), as did that to trimethoprim (98.4%-82.4%) and to tetracycline (96.5%-80.1%). The proportion of MRSA isolated increased
in Sydney, Melbourne, Canberra, Adelaide, Perth, and Darwin, but not in Brisbane. The proportion in Hobart peaked in 1994. MRSA in Perth were predominantly non-multiresistant (nmMRSA) throughout the survey
(
i.e
., resistant to less than three of eight indicator antibiotics) due mainly to local strains that originated in the community. The proportion of nmMRSA increased to modest levels in the other
cities. In eastern cities, this was due to the appearance of strains closely related to nmMRSA seen in other countries of the southwestern Pacific.</description><subject>Anti-Infective Agents - pharmacology</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Australia - epidemiology</subject><subject>Cities</subject><subject>Cross Infection - microbiology</subject><subject>Drug Resistance, Bacterial</subject><subject>Epidemiology</subject><subject>Hospitals, Teaching</subject><subject>Humans</subject><subject>Methicillin Resistance</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology</subject><subject>Polls & surveys</subject><subject>Public health</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Time Factors</subject><issn>1076-6294</issn><issn>1931-8448</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkU1LHEEQhhuJxFXzBzyEIYecHO3vj-OyGBUEwY9jGGp7amIvsz2b7pnD_ntbdiFgDnp6i6qnXqh6CTlj9IJR6y4ZNVpzR4XRynJtJDsgM-YEq62U9kupC1AXQh6R45xXlFLFtPhKjhi3nFpKZ-T3PI5hHXwalgH66gFzyCNEj1WI1eMIm5dtP_jB-ylXMCUsUgbzKY8J-gCxekLwLyH-qW6GvAkj9Pm8Ys66mjnnTslhVzr4ba8n5PnX1dPipr67v75dzO9qL6keayVa4ZXCzktNFVfQGg4dXzow1mLLgBtrwIoOjWtVpyV6JbXnHbYgOIA4IT93vps0_J0wj806ZI99DxGHKTdGSCGNdR-CzBrnjOMF_PEOXA1TiuWIhlPpuNWGFYjvoPK-nBN2zSaFNaRtw2jzFlHzf0Rl6fveeVqusf23ss-kAHYHvLUhxj7gEtP4Ge9Xol-cAQ</recordid><startdate>20030601</startdate><enddate>20030601</enddate><creator>Nimmo, Graeme R.</creator><creator>Bell, Jan M.</creator><creator>Mitchell, David</creator><creator>Gosbell, Iain B.</creator><creator>Pearman, John W.</creator><creator>Turnidge, John D.</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20030601</creationdate><title>Antimicrobial Resistance in Staphylococcus aureus in Australian Teaching Hospitals, 1989-1999</title><author>Nimmo, Graeme R. ; Bell, Jan M. ; Mitchell, David ; Gosbell, Iain B. ; Pearman, John W. ; Turnidge, John D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-53d3c55efc460525ad72af2b9a788ed1a2787a83fe79d5f64ec546c2feda32aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Anti-Infective Agents - pharmacology</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Australia - epidemiology</topic><topic>Cities</topic><topic>Cross Infection - microbiology</topic><topic>Drug Resistance, Bacterial</topic><topic>Epidemiology</topic><topic>Hospitals, Teaching</topic><topic>Humans</topic><topic>Methicillin Resistance</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology</topic><topic>Polls & surveys</topic><topic>Public health</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nimmo, Graeme R.</creatorcontrib><creatorcontrib>Bell, Jan M.</creatorcontrib><creatorcontrib>Mitchell, David</creatorcontrib><creatorcontrib>Gosbell, Iain B.</creatorcontrib><creatorcontrib>Pearman, John W.</creatorcontrib><creatorcontrib>Turnidge, John D.</creatorcontrib><creatorcontrib>AGAR</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Microbial drug resistance (Larchmont, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nimmo, Graeme R.</au><au>Bell, Jan M.</au><au>Mitchell, David</au><au>Gosbell, Iain B.</au><au>Pearman, John W.</au><au>Turnidge, John D.</au><aucorp>AGAR</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial Resistance in Staphylococcus aureus in Australian Teaching Hospitals, 1989-1999</atitle><jtitle>Microbial drug resistance (Larchmont, N.Y.)</jtitle><addtitle>Microb Drug Resist</addtitle><date>2003-06-01</date><risdate>2003</risdate><volume>9</volume><issue>2</issue><spage>155</spage><epage>160</epage><pages>155-160</pages><issn>1076-6294</issn><eissn>1931-8448</eissn><abstract>An annual survey of antimicrobial resistance in clinical isolates of
Staphylococcus aureus
was conducted in 21 Australian teaching hospital microbiology laboratories in eight major cities from 1989
to 1999. A total of 19,000 isolates were tested for susceptibility to 18 antimicrobials, with 3795 being methicillin-resistant (MRSA). Resistance to ciprofloxacin in MRSA increased from 4.9% to 75.9%. The
proportion of MRSA resistant to erythromycin decreased significantly (99.0%-88.9%), as did that to trimethoprim (98.4%-82.4%) and to tetracycline (96.5%-80.1%). The proportion of MRSA isolated increased
in Sydney, Melbourne, Canberra, Adelaide, Perth, and Darwin, but not in Brisbane. The proportion in Hobart peaked in 1994. MRSA in Perth were predominantly non-multiresistant (nmMRSA) throughout the survey
(
i.e
., resistant to less than three of eight indicator antibiotics) due mainly to local strains that originated in the community. The proportion of nmMRSA increased to modest levels in the other
cities. In eastern cities, this was due to the appearance of strains closely related to nmMRSA seen in other countries of the southwestern Pacific.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>12820800</pmid><doi>10.1089/107662903765826741</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1076-6294 |
| ispartof | Microbial drug resistance (Larchmont, N.Y.), 2003-06, Vol.9 (2), p.155-160 |
| issn | 1076-6294 1931-8448 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73434789 |
| source | Mary Ann Liebert Online Subscription; MEDLINE |
| subjects | Anti-Infective Agents - pharmacology Antibiotics Antimicrobial agents Australia - epidemiology Cities Cross Infection - microbiology Drug Resistance, Bacterial Epidemiology Hospitals, Teaching Humans Methicillin Resistance Microbial Sensitivity Tests Microbiology Polls & surveys Public health Staphylococcal Infections - epidemiology Staphylococcal Infections - microbiology Staphylococcus aureus - drug effects Time Factors |
| title | Antimicrobial Resistance in Staphylococcus aureus in Australian Teaching Hospitals, 1989-1999 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A25%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20Resistance%20in%20Staphylococcus%20aureus%20in%20Australian%20Teaching%20Hospitals,%201989-1999&rft.jtitle=Microbial%20drug%20resistance%20(Larchmont,%20N.Y.)&rft.au=Nimmo,%20Graeme%20R.&rft.aucorp=AGAR&rft.date=2003-06-01&rft.volume=9&rft.issue=2&rft.spage=155&rft.epage=160&rft.pages=155-160&rft.issn=1076-6294&rft.eissn=1931-8448&rft_id=info:doi/10.1089/107662903765826741&rft_dat=%3Cproquest_cross%3E73434789%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204928671&rft_id=info:pmid/12820800&rfr_iscdi=true |